以HSP-27为靶点的反义寡核甘酸正处于第二期临床试验中。
Phase II trials with an antisense oligonucleotide against HSP-27 in CRPC are underway.
五个非洲国家目前正在开展候选艾滋病毒疫苗的一期和二期临床试验：博茨瓦纳、肯尼亚、卢旺达、南非、乌干达，坦桑尼亚很快也将介入。
Five African countries are currently conducting phase I and phase II clinical trials of candidate HIV vaccines: Botswana, Kenya, Rwanda, South Africa, Uganda, soon to be joined by Tanzania.
应用推荐